Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Legal & Privacy Officer | June 09, 2022 | July 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date June 09, 2022 · Filed July 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,130 |
Ending reported balance
After 2022-07-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-09 · Exercise / conversion · Acquired 7,813 · Balance 53,130 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2022-07-20 · Sale · Disposed 1,000 · Balance 52,130 F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. |
| Performance Stock UnitSEC Table II · derivative / convertible security | Direct | 7,812 |
Reported balance
After 2022-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-09 · Exercise / conversion · Disposed 7,813 · Balance 7,812 F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,562 | $20.00 | $31,240.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Mar 29, 2021 21:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,468 | $97.33 | $532,200.44 |
DisclosureSEC source: 0001666071-21-000045 · wf-form4_161705199578183.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,841 Read SEC document |
| November 06, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 10,000 | $88.00 | $880,000.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,012 Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:35 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $82.41 | $247,230.00 |
DisclosureSEC source: 0001666071-20-000272 · wf-form4_160313968170748.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,012 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $72.01 | $216,030.00 |
DisclosureSEC source: 0001666071-20-000264 · wf-form4_160046000546520.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,012 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,051 | $81.70 | $85,866.70 |
DisclosureSEC source: 0001666071-20-000260 · wf-form4_159864539212670.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,012 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $81.51 to $81.98, inclusive. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 600 | $80.82 | $48,492.00 |
DisclosureSEC source: 0001666071-20-000260 · wf-form4_159864539212670.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,063 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $80.51 to $81.16, inclusive. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,909 | $80.10 | $152,910.90 |
DisclosureSEC source: 0001666071-20-000260 · wf-form4_159864539212670.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,663 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $79.51 to $80.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000260 · wf-form4_159864539212670.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,812 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification. F6 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 7,812 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000260 · wf-form4_159864539212670.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 17, 2020 Filed Aug 17, 2020 23:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $81.73 | $245,190.00 |
DisclosureSEC source: 0001666071-20-000252 · wf-form4_159770704295081.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,760 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020. Read SEC document |
| August 13, 2020 Filed Aug 13, 2020 23:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 82 | $79.50 | $6,519.00 |
DisclosureSEC source: 0001666071-20-000246 · wf-form4_159736075827496.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,760 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000246 · wf-form4_159736075827496.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,842 F2 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000246 · wf-form4_159736075827496.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs are immediately vested. F4 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000246 · wf-form4_159736075827496.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs are immediately vested. F4 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000246 · wf-form4_159736075827496.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 22:45 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $75.26 | $225,780.00 |
DisclosureSEC source: 0001666071-20-000206 · wf-form4_159528510230183.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,042 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000185 · wf-form4_159234158635447.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,042 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 385 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000183 · wf-form4_159173837259269.xml · derivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common Stock · 385 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-20-000183 · wf-form4_159173837259269.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,813 Underlying: Common Stock · 3,125 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 385 | $79.47 | $30,595.95 |
DisclosureSEC source: 0001666071-20-000183 · wf-form4_159173837259269.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,442 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,125 | $79.54 | $248,562.50 |
DisclosureSEC source: 0001666071-20-000183 · wf-form4_159173837259269.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,827 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $79.41 to $79.655, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 385 | $20.00 | $7,700.00 |
DisclosureSEC source: 0001666071-20-000183 · wf-form4_159173837259269.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,125 | $30.44 | $95,125.00 |
DisclosureSEC source: 0001666071-20-000183 · wf-form4_159173837259269.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 917 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000157 · wf-form4_159078255178188.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,208 Underlying: Common Stock · 917 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,108 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000157 · wf-form4_159078255178188.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 778 Underlying: Common Stock · 13,108 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 917 | $20.00 | $18,340.00 |
DisclosureSEC source: 0001666071-20-000157 · wf-form4_159078255178188.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 13,108 | $20.00 | $262,160.00 |
DisclosureSEC source: 0001666071-20-000157 · wf-form4_159078255178188.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 27, 2020 22:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,823 | $66.81 | $188,604.63 |
DisclosureSEC source: 0001666071-20-000150 · wf-form4_159061694170193.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,417 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on May 25, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $66.81 to $67.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| May 25, 2020 Filed May 27, 2020 22:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000150 · wf-form4_159061694170193.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,624 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. F4 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| May 25, 2020 Filed May 27, 2020 22:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 7,813 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000150 · wf-form4_159061694170193.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 94 | $67.82 | $6,375.08 |
DisclosureSEC source: 0001666071-20-000148 · wf-form4_159019728022062.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,427 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000148 · wf-form4_159019728022062.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 332 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs are immediately vested. F4 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000148 · wf-form4_159019728022062.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332 Underlying: Common Stock · 332 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs are immediately vested. F4 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000148 · wf-form4_159019728022062.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 271 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,000 | $58.25 | $116,500.00 |
DisclosureSEC source: 0001666071-20-000137 · wf-form4_159000902954732.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,918 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| April 17, 2020 Filed Apr 20, 2020 21:00 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,000 | $47.71 | $95,420.00 |
DisclosureSEC source: 0001666071-20-000115 · wf-form4_158741639800929.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,918 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| April 01, 2020 Filed Apr 14, 2020 00:49 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 33,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000101 · wf-form4_158682536964684.xml · derivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,871 Underlying: Common Stock · 33,871 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 20:14 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,000 | $44.57 | $89,140.00 |
DisclosureSEC source: 0001666071-20-000085 · wf-form4_158456243766535.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,918 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 300 | $45.68 | $13,704.00 |
DisclosureSEC source: 0001666071-20-000080 · wf-form4_158396900551699.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,918 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on February 26, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $45.15 to $46.01, inclusive. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,488 | $44.52 | $110,765.76 |
DisclosureSEC source: 0001666071-20-000080 · wf-form4_158396900551699.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,218 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on February 26, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $44.06 to $45.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 26, 2020 Filed Mar 3, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000046 · wf-form4_158319565110412.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,437 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification, and have not yet been delivered. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification. F3 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification, and have not yet been delivered. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| February 26, 2020 Filed Mar 3, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 7,813 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000046 · wf-form4_158319565110412.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares which have not been delivered. F2 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 01:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,562 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-20-000028 · wf-form4_158207662116886.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Stock · 1,562 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. F3 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 01:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 781 | $102.41 | $79,982.21 |
DisclosureSEC source: 0001666071-20-000028 · wf-form4_158207662116886.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,893 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $102.40 to $102.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 01:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,781 | $100.00 | $278,100.00 |
DisclosureSEC source: 0001666071-20-000028 · wf-form4_158207662116886.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,674 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 01:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,000 | $98.12 | $196,240.00 |
DisclosureSEC source: 0001666071-20-000028 · wf-form4_158207662116886.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,455 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 01:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,562 | $30.44 | $47,547.28 |
DisclosureSEC source: 0001666071-20-000028 · wf-form4_158207662116886.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| February 06, 2020 Filed Feb 6, 2020 21:55 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,000 | $90.00 | $180,000.00 |
DisclosureSEC source: 0001666071-20-000022 · wf-form4_158102610392228.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,893 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 778 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,886 Underlying: Common Stock · 778 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. F5 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.